News
Healthcare Providers Direct Appointments Three to Fill Key Management Positions
LAWRENCEVILLE, N.J.-(Business Wire)-March 29, 2007 - Healthcare Providers Direct, Inc. (OTCBB:HPRD) took a major step toward building its management team with the appointment of three pharmaceutical company veterans. Norman R. Proulx, the firm's President and CEO, announced today the appointments of Kathleen M. Philippi, Jack O'Connor and Charles Santino to key positions in product marketing, branding, communications and sales.
"We are bringing accomplished executives on board who have solid records of success in this industry. These appointments underscore how we are putting an experienced team into place to manage business, product and market development processes that we believe will work together to enhance the value of the company's portfolio of upcoming product opportunities," Proulx said. "The fact that we are able to attract this caliber of managers bodes well for our company. As HPRD grows, the responsibility to evaluate and implement our corporate strategies will become increasingly more challenging and critical. We believe that Kathleen, Jack and Charles will be immediate and significant contributors to our ongoing exploitation of new business opportunities in the coming months and years."
Ms. Philippi comes to HPRD with eleven years of pharmaceutical industry experience in strategic marketing and management. Her broad experience includes working with consumer insight teams to measure value, impact and return on investment, including quantitative and qualitative measures as part of formulating and recommending strategies and tactics for the launch of new products. She was also an integral member of the marketing team behind the launch of a nationwide heart failure awareness program. She has been appointed Director of Marketing at HPRD where she will oversee strategic product marketing, communications and promotions.
Mr. O'Connor is an accomplished sales manager with an expansive knowledge of the medical diagnostics industry and advanced medical technology sales processes. He established and directed national sales objectives to realize sales growth and gain competitive market edge for several companies including Beckman Coulter and Bayer Corporation. He will serve as Director of National Sales for HPRD.
Mr. Santino joins HPRD from American Bio Medica where he was a leading sales representative selling point-of-care tests used to treat abuse & alcohol conditions to occupational health clinics, doctors, hospitals, government agencies and rehabilitation centers. His experience handling inside distributor accounts and strategic partnerships will add support to the company's sales strategy. Mr. Santino will be responsible for establishing similar programs for the HPRD product portfolio as he leads the firm's inside sales initiative as Manager, Inside Sales.
Healthcare Providers Direct is a newly formed public company, as of February 2007, with a unique business model focused on the growing U.S. point-of-care (POC) healthcare market. HPRD has developed a "direct-to-doctor" multi-dimensional marketing communication model, coupled with "novel" (new) and "legacy" (existing) FDA-approved diagnostic products, to deliver these products and services cost-effectively to physicians' offices, public health facilities, and selective alternative care businesses in the professional POC segment of the U.S. healthcare market. Their website is available for viewing at http://www.healthcareprovidersdirect.com/.
Forward-Looking Statements:
Forward-looking statements such as "believe," "expect," "may," "plan," "intend," etc., contained herein are within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties and are based on the company's beliefs and assumptions it made using information currently available to it and which reflect current views concerning those future events. Actual results could differ materially. Therefore, undue reliance should not be placed on any forward-looking statements, since they apply only as of today's date, and accordingly, reference should be made to the company's periodic filings with the SEC.
